Package 1
This tender has been awarded
Awarded to Urtica Spółka z ograniczoną odpowiedzialnością; JANSSEN-CILAG POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; NEUCA SPÓŁKA AKCYJNA — €33,522,447
About This Opportunity
TranslatedThis tender concerns the supply of medicines under drug programs, specifically for Package 1. The medicines are to be delivered to the contracting authority's headquarters in Krakow. The required validity/warranty period for the supplied products must be at least 12 months from the date of delivery. For enteral and parenteral nutrition products, the minimum warranty period is 12 months, but not less than 6 months. The tender specifies that only medicines listed on the NFZ (National Health Fund) reimbursement lists are permitted for drug programs and chemotherapy, and their price must not exceed the NFZ financing limits. The contracting authority has also provided specific abbreviations for drug forms, such as 'tabl.' (tablets) and 'kaps.' (capsules), indicating that all types of tablets or capsules are acceptable under these designations.
This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from Polish1. The subject of the order is the delivery of medicines under drug programs according to 4 packages to the Ordering Party's registered office (Kraków, os. Złotej Jesieni 1), in accordance with the description and requirements contained in Annex No. 1 to these Specifications - in the scope of package No. 1. 2. The expiry date / warranty period of the subject of the order: may not be shorter than 12 months from the date of delivery, and for products for enteral and oral nutrition - not shorter than 12 months, but not shorter than 6 months. 3. In drug and chemotherapy programs, only drugs included in the NFZ refund lists are allowed (the price of the drug may not exceed the financing limit set by the NFZ). 4. The Ordering Party, by including the dosage form of the drug in the Specifications, e.g. "tabl.", means all types of tablets, "kaps." means all types of capsules, etc. In other cases, the dosage form is precisely specified, e.g. "tabl. dojelitowa" means that only enteric-coated tablets are allowed. 5. The medicinal product, which is the subject of the order, should be understood as medicinal products within the meaning of the Pharmaceutical Law of September 6, 2001 (Journal of Laws of 2024, item 686, as amended). The offered medicinal product must be authorized for circulation on the principles specified in Art. 3 or 4 sec. 1 and 2 or 4a of the Pharmaceutical Law. 6. The Ordering Party, in the execution of this order regarding the transport of the medicinal product to the Ordering Party's registered office, allows the participation of subcontractors with the necessary permits. 7. Other terms of the order are specified in the draft contract, which is Annex No. 3 to the Specifications.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on April 3, 2026. Last refreshed 8 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Sp. z o.o.
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Sp. z o.o. has issued 135 procurement notices on BidsFactory, including 4 currently open and 80 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: August 12, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
Urtica Spółka z ograniczoną odpowiedzialnością; JANSSEN-CILAG POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; NEUCA SPÓŁKA AKCYJNA was awarded the contract for €33,522,447. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Urtica Spółka z ograniczoną odpowiedzialnością; JANSSEN-CILAG POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; NEUCA SPÓŁKA AKCYJNA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Sp. z o.o. in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.